Changeflow GovPing Healthcare Visual Field Testing Method and Device
Routine Notice Added Final

Visual Field Testing Method and Device

Favicon for changeflow.com ChangeBridge: Patent Apps - Diagnosis & Surgery (A61B)
Published March 26th, 2026
Detected March 30th, 2026
Email

Summary

The USPTO published patent application US20260083318A1 for a visual field testing method and device. The invention, filed July 23, 2025, describes a method using display equipment with a detection interface where central and peripheral targets are presented according to preset strategies, with subject responses determining testing results. This affects medical device manufacturers developing diagnostic ophthalmic equipment.

What changed

The USPTO published a patent application for a visual field testing method and device (Application US20260083318A1, published March 26, 2026). The invention covers display-based visual field testing where a central stimulus point is presented for a first duration, followed by central and peripheral targets displayed according to a preset strategy. Subject responses to trigger operations determine both response results and the target position area for subsequent rounds of testing. The application identifies six inventors and classifies under CPC codes A61B 3/024, A61B 3/0058, and A61B 3/0091.\n\nMedical device manufacturers developing visual field or perimetry testing equipment should review this patent to understand potential intellectual property considerations. Healthcare providers using such diagnostic devices should be aware that new testing technologies may enter the market. No compliance deadlines or penalties are associated with this patent publication as it does not create regulatory obligations.

Source document (simplified)

← USPTO Patent Applications

METHOD AND DEVICE FOR VISUAL FIELD TESTING

Application US20260083318A1 Kind: A1 Mar 26, 2026

Inventors

Xiaolin MEI, Ming Yan CHEONG, Lok Hin CHAN, Lai Lin TSANG, Lilin CHEN, Bik Chi SUEN

Abstract

A method and a device for visual field testing are provided. The method is applied to a piece of display equipment which includes a display for presenting a detection interface. Within a preset first duration, a central stimulus point is displayed on the detection interface. Within a preset second duration, a central target and a peripheral target are displayed on the detection interface based on a preset target display strategy. In response to a subject's first trigger operation on the detection interface, a first response result corresponding to the first trigger operation and a target position area of a next round of display of the peripheral target are determined. Further, a testing result of the subject is determined based on the first response results corresponding to a preset number of detections.

CPC Classifications

A61B 3/024 A61B 3/0058 A61B 3/0091

Filing Date

2025-07-23

Application No.

19277927

View original document →

Classification

Agency
USPTO
Published
March 26th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260083318A1

Who this affects

Applies to
Medical device makers Healthcare providers Patients
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Manufacturing Diagnostic Testing
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Legal
Topics
Medical Devices Consumer Protection

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Apps - Diagnosis & Surgery (A61B) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.